Literature DB >> 9915526

Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes.

J T Williams1, S S Southerland, J Souza, A F Calcutt, R G Cartledge.   

Abstract

Wound healing is the response of tissue to injury that results in scar formation. Tissue regeneration would be a more ideal response. Previously, we have isolated a population of cells from avian, rodent, and rabbit skeletal muscle capable of differentiating into multiple mesodermal phenotypes. The present experiments were designed to determine whether a similar population of cells exist in human skeletal muscle. Separate cell preparations from skeletal muscle on an amputated leg of a 75-year-old female and the pectoralis muscle of a 27-year-old male were enzymatically dissociated and cultured to confluence in Eagle's minimal essential medium with 10 per cent preselected horse serum, then trypsinized, filtered, and slowly frozen in 7.5 per cent dimethylsulfoxide to -80 degrees C. The cells were thawed and plated with the same media plus dexamethasone (a nonspecific differentiation agent) at 10(-10) - 10(-6) M concentrations for up to 6 weeks. Immunological and histochemical staining assays were performed. Phenotypes observed included stem cells with typical stellate morphology (control), skeletal myotubes (anti-myosin), smooth muscle (anti-a-actin), bone (von Kossa stain), cartilage (Alcec blue), and fat (Sudan black B). These experiments establish the existence of a population of mesenchymal stem cells in human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. The possibility exists of manipulating the mesenchymal stem cells to achieve appropriate regeneration of mesenchymal tissues in the injured patient.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9915526

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  54 in total

1.  Human embryonic stem cell-derived mesenchymal stromal cells.

Authors:  Peiman Hematti
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

2.  Expression pattern of embryonic stem cell markers in DFAT cells and ADSCs.

Authors:  Qian Gao; Lili Zhao; Ziyi Song; Gongshe Yang
Journal:  Mol Biol Rep       Date:  2012-01-12       Impact factor: 2.316

Review 3.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 4.  Stem cells: novel players in the treatment of erectile dysfunction.

Authors:  Haiyang Zhang; Maarten Albersen; Xunbo Jin; Guiting Lin
Journal:  Asian J Androl       Date:  2011-10-17       Impact factor: 3.285

5.  Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus.

Authors:  Dongyan Shi; Dandan Wang; Xia Li; Huayong Zhang; Nan Che; Zhimin Lu; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2012-05       Impact factor: 2.980

6.  Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art.

Authors:  Arianna Malgieri; Eugenia Kantzari; Maria Patrizia Patrizi; Stefano Gambardella
Journal:  Int J Clin Exp Med       Date:  2010-09-07

7.  Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC).

Authors:  Igor B Resnick; Claudine Barkats; Michael Y Shapira; Polina Stepensky; Allan I Bloom; Avichai Shimoni; David Mankuta; Nira Varda-Bloom; Lyudmila Rheingold; Moshe Yeshurun; Bella Bielorai; Amos Toren; Tsila Zuckerman; Arnon Nagler; Reuven Or
Journal:  Am J Blood Res       Date:  2013-08-19

8.  Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.

Authors:  Changhui Zhou; Bo Yang; Yi Tian; Hongliang Jiao; Wendi Zheng; Jian Wang; Fangxia Guan
Journal:  Cell Immunol       Date:  2011-09-29       Impact factor: 4.868

9.  Synchronized reconstitution of muscle fibers, peripheral nerves and blood vessels by murine skeletal muscle-derived CD34(-)/45 (-) cells.

Authors:  Tetsuro Tamaki; Yoshinori Okada; Yoshiyasu Uchiyama; Kayoko Tono; Maki Masuda; Mika Wada; Akio Hoshi; Akira Akatsuka
Journal:  Histochem Cell Biol       Date:  2007-08-29       Impact factor: 4.304

Review 10.  Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.

Authors:  Jana Katuchova; Denisa Harvanova; Timea Spakova; Rastislav Kalanin; Daniel Farkas; Peter Durny; Jan Rosocha; Jozef Radonak; Daniel Petrovic; Dario Siniscalco; Meirigeng Qi; Miroslav Novak; Peter Kruzliak
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.